ProCE Banner Series

Management of Tardive Dyskinesia With Considerations For Special Populations: Helping Our Patients Age Well

Plan to attend CCO’s satellite symposium at the 2024 Gerontological Advanced Practice Nurses Association (GAPNA) Annual Conference in person or virtually to learn about best practices for screening, assessment, and treatment of tardive dyskinesia in older patients.

Meeting space has been assigned to provide an Industry Supported Presentation Theater (ISPT) provided by Clinical Care Options, LLC and supported by Neurocrine Biosciences, Inc. during GAPNA’s 2024 Annual Conference, September 12 – September 14 in San Antonio. GAPNA’s assignment of meeting space does not imply product endorsement nor does GAPNA assume any responsibility for the educational content of the ISPT.

  ANCC
Who Should Attend

This program is intended for advance practice nurses who treat older patients at risk for tardive dyskinesia.

All Events

Management of Tardive Dyskinesia With Considerations For Special Populations: Helping Our Patients Age Well

Upcoming Events

September

11

2024

5:15 PM - 6:30 PM Central Time (CT)

In-person

San Antonio Marriott River Center, 101 Bowie St., San Antonio, Texas 78205

5:30 PM - 6:30 PM Central Time (CT)

Virtual

Faculty

ProCE Banner Faculty
Amber Hoberg, PMHNP-BC

Morningstar Family Medicine PLLC
Baptist Healthcare System
San Antonio, Texas

ProCE Banner Faculty
Martha Sajatovic, MD

Professor of Psychiatry and of Neurology
Willard Brown Chair in Neurological Outcomes Research
Rocco L. Motto Professorship in Child & Adolescent Psychiatry
Director, Neurological and Behavioral Outcomes Center
University Hospitals Cleveland Medical Center
Case Western Reserve University School of Medicine
Cleveland, Ohio

Topics

Tardive dyskinesia, schizophrenia, movement disorders

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Tardive Dyskinesia (TD).

Target Audience
This program is intended for advance practice nurses who treat older patients at risk for tardive dyskinesia. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify factors that put older individuals at risk for TD
  • Interpret screening tools for the identification of TD, including patient and caregiver reports
  • Assess the safety and efficacy of VMAT2 inhibitors in the management of TD in older adults and special populations
  • Construct an individualized treatment plan for patients with TD with age-related or other special characteristics

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Neurocrine Biosciences, Inc.